BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26854079)

  • 21. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
    Denollet J; Vrints CJ; Conraads VM
    Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus.
    Watson L; Midgley A; Pilkington C; Tullus K; Marks S; Holt R; Jones C; Beresford M
    Lupus; 2012 Apr; 21(5):496-501. PubMed ID: 22147846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Hassan W; Behiry E; Mahgoub M
    Arch Rheumatol; 2021 Mar; 36(1):47-55. PubMed ID: 34046568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cytapheresis on tumor necrosis factor receptor and on expression of CD63 in myeloperoxidase--antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Hasegawa M; Nishii C; Kabutan N; Kato M; Ohashi A; Nakai S; Murakami K; Tomita M; Nabeshima K; Hiki Y; Oshima H; Sugiyama S
    Ther Apher Dial; 2007 Oct; 11(5):337-40. PubMed ID: 17845393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
    Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
    Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Role of Soluble TNF-α Receptors in Diagnosis of Patients with Chronic Kidney Disease.
    Xun C; Zhao Y
    Ann Clin Lab Sci; 2017 May; 47(3):310-314. PubMed ID: 28667032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 and their potential as markers of immunoglobulin A nephropathy activity.
    Miedziaszczyk M; Oko A; Wolc A; Woźniak A; Idasiak-Piechocka I
    Adv Clin Exp Med; 2023 Nov; ():. PubMed ID: 37962255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
    Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity.
    Gupta R; Aggarwal A; Sinha S; Rajasekhar L; Yadav A; Gaur P; Misra R; Negi VS
    Lupus; 2016 Oct; 25(11):1230-6. PubMed ID: 26936893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis.
    Hassan AM; Farghal NMA; Hegab DS; Mohamed WS; Abd-Elnabi HH
    Clin Rheumatol; 2018 Nov; 37(11):3025-3032. PubMed ID: 30006918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Carlsson AC; Jansson JH; Söderberg S; Ruge T; Larsson A; Ärnlöv J
    Atherosclerosis; 2018 May; 272():41-46. PubMed ID: 29547707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
    El-Gohary A; Hegazy A; Abbas M; Kamel N; Nasef SI
    J Clin Lab Anal; 2016 Nov; 30(6):1135-1138. PubMed ID: 27184880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
    Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
    Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural damage in diabetic nephropathy is associated with TNF-α system activity.
    Fernández-Real JM; Vendrell J; García I; Ricart W; Vallès M
    Acta Diabetol; 2012 Aug; 49(4):301-5. PubMed ID: 22042131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.